Type 2 diabetes<span> is in the process of being redefined as an autoimmune disease rather than just a metabolic disorder, said an author of a new study published in </span>Nature Medicine<span> this week, the findings of which may lead to new diabetes treatments that target the immune system instead of trying to control blood sugar.</span>
